- Home
- XTNT vs NSPR Comparison
XTNT vs NSPR Comparison
Compare XTNT & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- NSPR
- Stock Information
- Founded
- XTNT N/A
- NSPR 2005
- Country
- XTNT United States
- NSPR United States
- Employees
- XTNT N/A
- NSPR N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- NSPR Medical/Dental Instruments
- Sector
- XTNT Health Care
- NSPR Health Care
- Exchange
- XTNT Nasdaq
- NSPR Nasdaq
- Market Cap
- XTNT 89.8M
- NSPR 99.7M
- IPO Year
- XTNT N/A
- NSPR N/A
- Fundamental
- Price
- XTNT $0.68
- NSPR $2.43
- Analyst Decision
- XTNT
- NSPR Strong Buy
- Analyst Count
- XTNT 0
- NSPR 2
- Target Price
- XTNT N/A
- NSPR $4.50
- AVG Volume (30 Days)
- XTNT 104.0K
- NSPR 119.2K
- Earning Date
- XTNT 11-11-2025
- NSPR 11-11-2025
- Dividend Yield
- XTNT N/A
- NSPR N/A
- EPS Growth
- XTNT N/A
- NSPR N/A
- EPS
- XTNT N/A
- NSPR N/A
- Revenue
- XTNT $127,766,000.00
- NSPR $7,066,000.00
- Revenue This Year
- XTNT $13.03
- NSPR $7.48
- Revenue Next Year
- XTNT N/A
- NSPR $104.39
- P/E Ratio
- XTNT N/A
- NSPR N/A
- Revenue Growth
- XTNT 15.16
- NSPR 7.60
- 52 Week Low
- XTNT $0.33
- NSPR $1.99
- 52 Week High
- XTNT $0.78
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- XTNT 58.12
- NSPR 49.95
- Support Level
- XTNT $0.62
- NSPR $2.38
- Resistance Level
- XTNT $0.67
- NSPR $2.57
- Average True Range (ATR)
- XTNT 0.04
- NSPR 0.07
- MACD
- XTNT 0.00
- NSPR 0.01
- Stochastic Oscillator
- XTNT 79.83
- NSPR 34.24
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.